{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:20:14Z","timestamp":1788981614004,"version":"build-2803163510"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271107"],"award-info":[{"award-number":["82271107"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Provincial Health Commission Medical Research Key Project","award":["K2023060"],"award-info":[{"award-number":["K2023060"]}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"crossref","award":["BK20221186"],"award-info":[{"award-number":["BK20221186"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Postgraduate Research and Practice Innovation Program of Jiangsu Province","award":["JX10414318"],"award-info":[{"award-number":["JX10414318"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To investigate the impact of anti\u2013vascular endothelial growth factor therapy on epiretinal macrophage-like cells (eMLC) in branch retinal vein occlusion with macular edema\u00a0 (BRVO-ME) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective study included 58 BRVO-ME patients treated with anti\u2013vascular endothelial growth factor agents, divided into 2 groups: 28 eyes (1\u20132 Injection group) and 30 eyes (3 Injection group). The 3-injection group comprised 20 early responders and 10 limited early responders (LERs). Longitudinal changes in macular eMLC count and density were assessed through en face optical coherence tomography during the early response phase (baseline to 3 months postinitial injection). Linear regression and Spearman correlation analyzed eMLC density's relationship with optical coherence tomography angiography parameters and systemic inflammatory indices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The 3-injection group exhibited greater reductions in macular edema and eMLC density than the 1 to 2 injection group. Macular eMLC density significantly decreased in early responders, whereas LERs showed no significant alteration. Posttreatment central macular thickness change positively correlated with eMLC density change (r = 0.57). Baseline systemic inflammatory indices (neutrophil\/lymphocyte ratio, r = \u22120.46; neutrophil\/platelet ratio, r = \u22120.36; systemic immune-inflammation index, r = \u22120.33; systemic inflammatory response index, r = \u22120.31) negatively correlated with posttreatment eMLC density change.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Anti\u2013vascular endothelial growth factor therapy reduces macular eMLC in BRVO-ME patients, especially in early responders receiving three injections. Macular eMLCs are closely associated with inflammation and may serve as a valuable treatment response biomarker.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004723","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T20:00:09Z","timestamp":1762804809000},"page":"593-603","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["EPIRETINAL MACROPHAGE-LIKE CELL ALTERATIONS FOLLOWING ANTI\u2013VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN BRANCH RETINAL VEIN OCCLUSION WITH MACULAR EDEMA"],"prefix":"10.1097","volume":"46","author":[{"given":"Wen","family":"Bai","sequence":"first","affiliation":[{"name":"The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China;"},{"name":"The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[{"name":"The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China;"},{"name":"The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China;"},{"name":"The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yi","family":"Li","sequence":"additional","affiliation":[{"name":"The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China;"},{"name":"The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Shan","family":"Zhu","sequence":"additional","affiliation":[{"name":"The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Sun","sequence":"additional","affiliation":[{"name":"The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3319-4051","authenticated-orcid":false,"given":"Feng","family":"Wen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yao","sequence":"additional","affiliation":[{"name":"The Affiliated Eye Hospital, Nanjing Medical University, Nanjing, China;"},{"name":"The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260324","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)31559-2","article-title":"Retinal vascular occlusions","volume":"396","author":"Scott","year":"2020","journal-title":"Lancet"},{"key":"R2-20260324","first-page":"CD009510","article-title":"Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion","volume":"7","author":"Shalchi","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R3-20260324","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.oret.2023.08.005","article-title":"Long-term outcomes in early versus limited response to Anti-VEGF treatment for retinal vein occlusion","volume":"8","author":"Kailar","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"R4-20260324","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.preteyeres.2017.10.006","article-title":"Mechanisms of macular edema: beyond the surface","volume":"63","author":"Daruich","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"R5-20260324","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/iovs.62.10.2","article-title":"Macrophage-like cell density is increased in proliferative diabetic retinopathy characterized by optical coherence tomography angiography","volume":"62","author":"Ong","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-20260324","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1080\/09273948.2023.2254369","article-title":"In vivo visualization of macrophage-like cells in patients with uveitis by use of en face swept source optical coherence tomography","volume":"32","author":"Pichi","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"key":"R7-20260324","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1038\/s41598-023-32455-1","article-title":"Elevated number and density of macrophage-like cell as a novel inflammation biomarker in diabetic macular edema","volume":"13","author":"Wang","year":"2023","journal-title":"Sci Rep"},{"key":"R8-20260324","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/IAE.0000000000004100","article-title":"Epiretinal macrophage-like cells on optical coherence tomography: potential inflammatory imaging biomarker of severity in diabetic retinopathy","volume":"44","author":"Zeng","year":"2024","journal-title":"Retina"},{"key":"R9-20260324","doi-asserted-by":"crossref","first-page":"30661","DOI":"10.1073\/pnas.2010943117","article-title":"Label-free adaptive optics imaging of human retinal macrophage distribution and dynamics","volume":"117","author":"Hammer","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-20260324","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12974-022-02562-3","article-title":"Macrophages in close proximity to the vitreoretinal interface are potential biomarkers of inflammation during retinal vascular disease","volume":"19","author":"Rajesh","year":"2022","journal-title":"J Neuroinflammation"},{"key":"R11-20260324","doi-asserted-by":"crossref","first-page":"100475","DOI":"10.1016\/j.xops.2024.100475","article-title":"Label-free imaging of inflammation at the level of single cells in the living human eye","volume":"4","author":"Rui","year":"2024","journal-title":"Ophthalmol Sci"},{"key":"R12-20260324","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.3390\/jcm11195636","article-title":"Increased macrophage-like cell density in retinal vein occlusion as characterized by en face optical coherence tomography","volume":"11","author":"Wang","year":"2022","journal-title":"J Clin Med"},{"key":"R13-20260324","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1167\/iovs.61.6.48","article-title":"Imaging of macrophage-like cells in living human retina using clinical OCT","volume":"61","author":"Castanos","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-20260324","doi-asserted-by":"crossref","first-page":"855466","DOI":"10.3389\/fimmu.2022.855466","article-title":"Characterization of Macrophage-Like Cells in Retinal Vein Occlusion Using En Face Optical Coherence Tomography","volume":"13","author":"Zeng","year":"2022","journal-title":"Front Immunol"},{"key":"R15-20260324","first-page":"e65693","article-title":"A comprehensive review of ocular manifestations in systemic diseases","volume":"16","author":"Kumar","year":"2024","journal-title":"Cureus"},{"key":"R16-20260324","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/jpm13010045","article-title":"Macrophage-like cells are increased in retinal vein occlusion and correlate with more intravitreal injections and worse visual acuity outcomes","volume":"13","author":"Rangwani","year":"2022","journal-title":"J Personalized Med"},{"key":"R17-20260324","doi-asserted-by":"crossref","first-page":"1095296","DOI":"10.3389\/fimmu.2022.1095296","article-title":"Characteristics of macrophage-like cells in acute nonarteritic anterior ischemic optic neuropathy and the normal fellow eyes on en face optical coherence tomography","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"R18-20260324","first-page":"908","article-title":"Anti-vascular endothelial growth factor acts on retinal microglia\/macrophage activation in a rat model of ocular inflammation","volume":"20","author":"Couturier","year":"2014","journal-title":"Mol Vis"},{"key":"R19-20260324","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.18240\/ijo.2022.08.11","article-title":"Anti-VEGF reduces inflammatory features in macular edema secondary to retinal vein occlusion","volume":"15","author":"Qin","year":"2022","journal-title":"Int J Ophthalmol"},{"key":"R20-20260324","doi-asserted-by":"crossref","first-page":"e2211690119","DOI":"10.1073\/pnas.2211690119","article-title":"Vegf signaling between muller glia and vascular endothelial cells is regulated by immune cells and stimulates retina regeneration","volume":"119","author":"Mitra","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-20260324","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/OPTH.S37544","article-title":"Changes in the foveal microstructure after intravitreal bevacizumab application in patients with retinal vascular disease","volume":"7","author":"Feucht","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"R22-20260324","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3390\/jcm10071423","article-title":"Longitudinal changes on optical coherence tomography angiography in retinal vein occlusion","volume":"10","author":"Tripathy","year":"2021","journal-title":"J Clin Med"},{"key":"R23-20260324","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3390\/jcm11102892","article-title":"Retinal vessel density and treatment intensity among adults with retinal vein occlusion: a swept-source optical coherence tomography angiography study","volume":"11","author":"Cheng","year":"2022","journal-title":"J Clin Med"},{"key":"R24-20260324","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.3390\/diagnostics13193100","article-title":"An analysis of optical coherence tomography angiography (OCT-A) perfusion density maps in patients treated for retinal vein occlusion with intravitreal aflibercept","volume":"13","author":"Spiewak","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R25-20260324","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1167\/iovs.16-20579","article-title":"Optical coherence tomography angiography analysis of the foveal avascular zone and macular vessel density after Anti-VEGF therapy in eyes with diabetic macular edema and retinal vein occlusion","volume":"58","author":"Ghasemi Falavarjani","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-20260324","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4274\/tjo.galenos.2020.81592","article-title":"Vessel density changes on optical coherence tomography angiography after vascular endothelial growth factor inhibitor treatment for diabetic macular edema","volume":"50","author":"Cheong","year":"2020","journal-title":"Turk J Ophthalmol"},{"key":"R27-20260324","first-page":"188","article-title":"Review on recent trials evaluating the effect of intravitreal injections of Anti-VEGF agents on the macular perfusion of diabetic patients with diabetic macular edema","volume":"15","author":"Elnahry","year":"2020","journal-title":"Rev Recent Clin Trials"},{"key":"R28-20260324","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1167\/iovs.17-23437","article-title":"Changes in retinal microvasculature and visual acuity after antivascular endothelial growth factor therapy in retinal vein occlusion","volume":"59","author":"Winegarner","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R29-20260324","doi-asserted-by":"crossref","first-page":"951666","DOI":"10.3389\/fphar.2022.951666","article-title":"Efficacy of single-dose intravitreal dexamethasone implantation for retinal vein occlusion patients with refractory macular edema: a systematic review and meta-analysis","volume":"13","author":"Yuan","year":"2022","journal-title":"Front Pharmacol"},{"key":"R30-20260324","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/biomedicines13010105","article-title":"The diagnosis and treatment of branch retinal vein occlusions: an update","volume":"13","author":"Darabus","year":"2025","journal-title":"Biomedicines"},{"key":"R31-20260324","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2147\/OPTH.S513141","article-title":"From monotherapy to combination strategies: redefining treatment approaches for multiple-cause macular edema","volume":"19","author":"Zhu","year":"2025","journal-title":"Clin Ophthalmol"},{"key":"R32-20260324","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12944-024-02176-z","article-title":"Assessment of leukocyte and systemic inflammation index ratios in dyslipidemia patients with dry eye disease: a retrospective case\u2012control study","volume":"23","author":"Alhalwani","year":"2024","journal-title":"Lipids Health Dis"},{"key":"R33-20260324","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.18240\/ijo.2019.12.18","article-title":"Neutrophil-to-lymphocyte ratio in ocular diseases: a systematic review","volume":"12","author":"Kurtul","year":"2019","journal-title":"Int J Ophthalmol"},{"key":"R34-20260324","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4103\/ijo.IJO_2100_19","article-title":"Commentary: systemic immune-inflammatory indices and their association with ocular disorders-Do we have economical and reliable biomarkers?","volume":"68","author":"Madanagopalan","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"R35-20260324","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/joco.joco_44_23","article-title":"Systemic inflammatory marker levels in serous macular detachment secondary to retinal vein occlusion","volume":"35","author":"Dogan","year":"2023","journal-title":"J Curr Ophthalmol"},{"key":"R36-20260324","doi-asserted-by":"crossref","first-page":"e36512","DOI":"10.1097\/MD.0000000000036512","article-title":"Assessment of systemic inflammatory response index and other inflammatory indicators in retinal vein occlusion","volume":"102","author":"Ucer","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"R37-20260324","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/09273948.2022.2032199","article-title":"Assessment of systemic immune-inflammation index levels in patients with retinal vein occlusion","volume":"31","author":"Zuo","year":"2023","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004723","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:07:35Z","timestamp":1774368455000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004723"}},"subtitle":["A Retrospective Longitudinal Study"],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004723","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}